Home › Disorders of Excessive Somnolence › Washington › Spokane
Disorders of Excessive Somnolence clinical trials in Spokane, WA
3 studies for Disorders of Excessive Somnolence are looking for participants at sites in and around Spokane (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
RecruitingPhase 3
- Washington State University Sleep and Performance Center, Spokane
A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
RecruitingPhase 3
- Alkermes Investigational Site, Spokane
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
RecruitingPhase 3
- Clinical Research Site, Spokane
Disorders of Excessive Somnolence trials in other cities
- Cincinnati, OH9 studies
- Atlanta, GA9 studies
- San Antonio, TX9 studies
- Miami, FL8 studies
- Charlotte, NC8 studies
- Austin, TX7 studies
- Sugar Land, TX7 studies
- Columbia, SC7 studies
- Orlando, FL7 studies
- Lansing, MI6 studies
- Brandon, FL6 studies
- Staten Island, NY5 studies
Other studies in Spokane
- Non-Small Cell Lung Cancer10 studies
- Breast Cancer8 studies
- Ovarian Cancer8 studies
- Colorectal Cancer8 studies
- Parkinson's Disease8 studies
- Prostate Cancer7 studies
- Cancer (all types)6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Chronic Lymphocytic Leukemia6 studies
- Melanoma5 studies
- Triple-Negative Breast Cancer5 studies
- Geographic Atrophy5 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.